Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Navigating PSMA PET Radiopharmaceuticals: Clinical and Operational Factors.

AJR. American journal of roentgenology·2026
Same author

The Semicentenary Anniversary of FDG: A Momentous Milestone in Nuclear Medicine.

Clinical nuclear medicine·2026
Same author

Novel Theranostic Targets for Prostate Cancer Beyond Prostate-Specific Membrane Antigen.

PET clinics·2026
Same author

Update to the Appropriate Use Criteria for <sup>18</sup>F-FDG PET/CT for Initial Staging of Malignant Disease.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

A Conversation Between the Honorable NRC Commissioner David A. Wright and ACMUI Chair Hossein Jadvar.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Therapy strategies to defeat prostate cancer heterogeneity.

Seminars in nuclear medicine·2025

Related Experiment Video

Updated: Jun 4, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Prostate cancer.

Hossein Jadvar1

  • 1Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. jadvar@usc.edu

Methods in Molecular Biology (Clifton, N.J.)
|February 19, 2011
PubMed
Summary
This summary is machine-generated.

Prostate cancer imaging requires a personalized approach. Advanced positron emission tomography (PET) scans show promise for evaluating this heterogeneous disease in men.

More Related Videos

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

Related Experiment Videos

Last Updated: Jun 4, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

Area of Science:

  • Oncology
  • Medical Imaging
  • Nuclear Medicine

Background:

  • Prostate cancer is a complex disease with varied clinical behaviors.
  • Current imaging strategies must adapt to individual patient risk and disease stage.
  • Effective imaging is crucial for managing prostate cancer throughout its natural history.

Purpose of the Study:

  • To outline the natural history of prostate cancer.
  • To review current and emerging imaging modalities for prostate cancer.
  • To explore the role of positron emission tomography (PET) in prostate cancer evaluation.

Main Methods:

  • Review of prostate cancer natural history.
  • Discussion of established imaging tools and their limitations.
  • Analysis of preclinical and clinical data on PET radiotracers.

Main Results:

  • Prostate cancer heterogeneity necessitates tailored imaging strategies.
  • Various imaging tools offer specific benefits and challenges across disease phases.
  • Positron emission tomography (PET) shows emerging potential in prostate cancer assessment.

Conclusions:

  • Imaging evaluation for prostate cancer should be patient-specific and risk-adapted.
  • Positron emission tomography (PET) represents a promising advancement in prostate cancer imaging.
  • Further research into PET radiotracers can optimize diagnostic accuracy.